ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:10 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 229
Drug details and screening numbers
Drug Name: LY317615
Drug ID: 229
Synonyms: Enzastaurin
Brand name:
Target: PRKCB (PKCbeta)
Number of cell lines screened: 924
Screening concentration range(s): 0.078125 to 20 uM and 0.04 to 10.24 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a214 |
gain_cnaPANCAN18 |
229 |
1 |
1 |
LY317615 |
PRKCB (PKCbeta) |
52 |
869 |
3.00, 2.33 |
3.17 |
4.22 |
1.04 |
0.63 . |
0.62 . |
0.68 . |
1.01e-04 |
1.34e-25 |
9.64e-01 |
7.8 |
All-tests volcano plot